Brief: Valbiotis Has Received FDA Approval For NDI Status
Dec 12 (Reuters) - Valbiotis SA ALVAL.PA :
* ANNOUNCED ON MONDAY IT HAS RECEIVED FOOD AND DRUG
ADMINISTRATION
(FDA) APPROVAL FOR NEW DIETARY INGREDIENT (NDI) STATUS
Source text for Eikon: ID:nEQ9Drjzba
Further company coverage: ALVAL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Valbiotis SA
See all newsBrief: Valbiotis Announces Creation By Chinese JV Of Subsidiary In Singapore
French and Benelux stocks-Factors to watch
Brief: Valbiotis FY Operating Profit Eur -9.5 Mln
Brief: Valbiotis Launches Capital Increase For Gross Amount Of Nearly EUR 6.9 Mln
Brief: Valbiotis Signs Strategic Agreements With Two Pharmaceutical Groups